Masimo pre-announces Q2 revenue $453-457M, cuts FY2023 healthcare guidance to $1.30B

MASIMO CORP

2023-Q2 EPS reported $0.68 revenue$1,020,300,000

Q2 consolidated revenue $453-457M: healthcare $280-282M, non-healthcare $173-175M.
Healthcare miss due to delayed large orders, lower hospital census, elevated sensor inventory.
Non-healthcare softness extended to premium audio; Stork monitor and hearables sales strong.
Lowers FY2023 healthcare revenue floor to $1.30B (from $1.45B); non-healthcare to $800-850M.
Unrecognized Contract Revenue $1.37-1.38B (+11-12% YoY); company taking cost actions.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MASIMO CORP reported second quarter ended July 1, 2023 results: revenue consolidated revenue expected to range from $453 million to $457 million.

Period: second quarter ended July 1, 2023
Revenue: consolidated revenue expected to range from $453 million to $457 million
Result: preliminary results

Exact text from the filing

Masimo expects its consolidated revenue for the second quarter 2023 to range from $453 million to $457 million, with healthcare revenue expected to range fro m $280 million to $282 million and non-healthcare revenue expected to range fro m $173 million to $175 million .

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MASIMO CORP reported fiscal year 2023 results: revenue healthcare revenue guidance reduced to lower end of $1.30 billion; non-healthcare revenue guidance reduced to $800 milli. Guidance lowered.

Period: fiscal year 2023
Revenue: healthcare revenue guidance reduced to lower end of $1.30 billion; non-healthcare revenue guidance reduced to $800 milli
Guidance: lowered
Result: guidance update

Exact text from the filing

We currently expect to reduce the lower end of full year revenue guidance for the healthcare business to $1.30 billion from $1.45 billion. We are still evaluating the upper end of revenue guidance for the healthcare business, but it could be materially higher than the lower end of the range, as we are still targeting our original guidance. We also expect to reduce annual revenue guidance for the non-healthcare business to $800 million to $850 million from $965 million to $995 million.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-23-000185

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.